Avondale Wealth Management Johnson & Johnson Transaction History

Avondale Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 05, 2023	SELL	$151.05 - $180.26 $67,972 - $81,117	-450 Reduced 64.29%	250 $38,000
Q3 2022 Oct 07, 2022	BUY	$161.33 - $179.52 $112,931 - $125,664	700 New	700 $114,000
Q2 2022 Jul 11, 2022	SELL	$168.19 - $186.01 $5,045 - $5,580	-30 Closed	0 $0
Q1 2022 Apr 12, 2022	BUY	$158.14 - $179.59 $4,744 - $5,387	30 New	30 $5,000
Q2 2018 Jul 06, 2018	SELL	$119.4 - $131.76 $15,044 - $16,601	-126 Closed	0 $0
Q4 2017 Apr 27, 2018	BUY	$131.22 - $143.62 $16,533 - $18,096	126	126 $18,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Avondale Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Avondale Wealth Management with notifications on news.